Cargando…

Association of JAK/STAT genetic variants with cutaneous melanoma

BACKGROUND: The Janus-activated kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway regulates cutaneous melanoma (CM) development and progression. The JAK1, JAK2, and STAT3 proteins are encoded by polymorphic genes. This study aimed to verify whether single-nucleot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomez, Gabriela Vilas Bôas, Lourenço, Gustavo Jacob, Monteiro, Lummy Maria Oliveira, Rocha, Rafael Silva, Fernández, Kimberly Anne McGrail, Recio, Juan Angel, Torricelli, Caroline, Coser, Lilian Oliveira, Oliveira, Alexandre Leite Rodrigues, Carron, Juliana, Moraes, Aparecida Machado, Lima, Carmen Silvia Passos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379289/ https://www.ncbi.nlm.nih.gov/pubmed/35982955 http://dx.doi.org/10.3389/fonc.2022.943483

Ejemplares similares

Inherited variations in human pigmentation-related genes modulate cutaneous melanoma risk and clinicopathological features in Brazilian population
por: Lourenço, Gustavo Jacob, et al.
Publicado: (2020)

Calibrating Transcriptional Activity Using Constitutive Synthetic Promoters in Mutants for Global Regulators in Escherichia coli
por: Sanches-Medeiros, Ananda, et al.
Publicado: (2018)

JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

Prognostic value of key genes of the JAK-STAT signaling pathway in patients with cutaneous melanoma
por: Pan, Fuqiang, et al.
Publicado: (2020)

Association of Inherited Copy Number Variation in ADAM3A and ADAM5 Pseudogenes with Oropharynx Cancer Risk and Outcome
por: Carron, Juliana, et al.
Publicado: (2022)

Unraveling the Complex Interplay of Fis and IHF Through Synthetic Promoter Engineering
por: Monteiro, Lummy Maria Oliveira, et al.
Publicado: (2020)

A JAK/STAT invasion
por: Wells, William A.
Publicado: (2002)

JAK-STAT and bone metabolism
por: Li, Jiliang
Publicado: (2013)

The Drosophila JAK-STAT pathway
por: Zeidler, Martin P, et al.
Publicado: (2013)

Evolution of the JAK-STAT pathway
por: Liongue, Clifford, et al.
Publicado: (2013)

The JAK-STAT pathway at 20
por: Darnell, Jr., James E.
Publicado: (2012)

JAK-STAT in lymphoproliferative disorders
por: Rabadan, Raul, et al.
Publicado: (2015)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)

JAK/STAT as a Potential Therapeutic Target for Osteolytic Diseases
por: Godoi, Mariely A., et al.
Publicado: (2023)

Impact of JAK/STAT inhibitors on human monocyte‐derived‐macrophages stimulated by cigarette smoke extract and lipopolysaccharide
por: Verres, Yann, et al.
Publicado: (2022)

JAK-STAT in heterochromatin and genome stability
por: Silver-Morse, Louise, et al.
Publicado: (2013)

JAK-STAT and intestinal mucosal immunology
por: Heneghan, Aaron F, et al.
Publicado: (2013)

JAK-STAT: Getting to the heart of the matter
por: Barry, Sean P.
Publicado: (2012)

JAK-STAT pathway and myogenic differentiation
por: Jang, You-Na, et al.
Publicado: (2013)

JAK-STAT Signalling Pathway in Cancer
por: Brooks, Andrew J., et al.
Publicado: (2020)

JAK/STAT signaling in hepatocellular carcinoma
por: Hin Tang, Justin Jit, et al.
Publicado: (2020)

JAK-STAT in Early Hematopoiesis and Leukemia
por: Fasouli, Eirini Sofia, et al.
Publicado: (2021)

JAK-STAT pathway inhibitors in dermatology()
por: Miot, Hélio Amante, et al.
Publicado: (2023)

Transcriptional regulation by STAT1 and STAT2 in the interferon JAK-STAT pathway
por: Au-Yeung, Nancy, et al.
Publicado: (2013)

JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
por: Govaerts, Inge, et al.
Publicado: (2019)

Mrs. Einstein
por: McGrail, Anna
Publicado: (1998)

Surmortalité, COVID-19 et systèmes de santé au Canada
por: McGrail, Kimberlyn
Publicado: (2022)

Excess mortality, COVID-19 and health care systems in Canada
por: McGrail, Kimberlyn
Publicado: (2022)

Comparative analysis of the tissue inflammatory response in human cutaneous and disseminated leishmaniasis
por: Dantas, Marina Loyola, et al.
Publicado: (2014)

Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
por: Furqan, Muhammad, et al.
Publicado: (2013)

A review of JAK–STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition
por: McInnes, Iain B, et al.
Publicado: (2021)

Expression of JAK3, STAT2, STAT4, and STAT6 in pemphigus vulgaris
por: Juczynska, K., et al.
Publicado: (2020)

Kinematic Changes during Prolonged Fast-Walking in Old and Young Adults
por: Oliveira, Camila Fonseca, et al.
Publicado: (2017)

Primary cutaneous anaplastic large-cell lymphoma - Case report
por: de Oliveira, Luciana Silveira Rabello, et al.
Publicado: (2013)

Laboratory Diagnosis of Cutaneous and Visceral Leishmaniasis: Current and Future Methods
por: Reimão, Juliana Quero, et al.
Publicado: (2020)

JAK3-STAT pathway blocking benefits in experimental lupus nephritis
por: Ripoll, Èlia, et al.
Publicado: (2016)

The JAK/STAT Pathway Is Involved in Synaptic Plasticity
por: Nicolas, Céline S., et al.
Publicado: (2012)

JAK/STAT signaling and human in vitro myogenesis
por: Trenerry, Marissa K, et al.
Publicado: (2011)

JAK-STAT signaling and myocardial glucose metabolism
por: Frias, Miguel A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_592quav792q52d87f6eq7ug42j